|Project Title||Sentinel Initiative Public Workshop - Twelfth Annual|
Monday, April 20, 2020
The Sentinel Initiative, an active medical product surveillance system, was established in response to the Food and Drug Administration (FDA) Amendments Act of 2007 and has become one of the Agency’s premier evidence generation platforms. The Twelfth Annual Sentinel Initiative Public Workshop was originally scheduled for April 20-21, 2020, but has been postponed until further notice.
If you have any questions or concerns, please email email@example.com.
Funding for this conference was made possible by a cooperative agreement from the Food and Drug Administration, Center for Drug Evaluation and Research. The views expressed in written conference materials and the speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsements by the U.S. Government.
Further event information and materials will be available at a later time.
- Vaccines, Blood & Biologics
- Devices and Radiologic Health